How do the new RxPONDER results affect your choice of adjuvant therapy for postmenopausal women with HR+/HER2 negative breast cancer and 1-3 positive lymph nodes?  

Would you send an Oncotype RS to determine the role of adjuvant chemotherapy and/or endocrine therapy?

Answer from: Medical Oncologist at Academic Institution
Medical Oncologist at Breastlink Medical Group
Agree with @Charles L. Shapiro. I think what a fut...
Medical Oncologist at University Medical Oncology
How do you look at Mammaprint in view of the above...
Sign in or Register to read more